SCHEMBL16705681

SCHEMBL16705681

CCCCC(CC)N(N)c1nc2ccccc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
ATP4A P20648 4/20 0.38
ATP4B P51164 4/20 0.38
UBE2T Q9NPD8 1/20 0.38
ASIC3 Q9UHC3 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16705643 0.85 NPC1 (0.48) NPC1RAB9AALDH1A1GAALOXL2
SCHEMBL15722636 0.76 NPC1 (0.52) NPC1RAB9AALDH1A1GAASMN1; SMN2
SCHEMBL24086156 0.76 NPC1 (0.45) NPC1RAB9AALDH1A1GAALOXL2
SCHEMBL20043130 0.75 LOXL2 (0.49) NPC1RAB9AALDH1A1GAALOXL2
SCHEMBL18369556 0.75 NPC1 (0.51) NPC1RAB9AALDH1A1GAALOXL2
SCHEMBL16705693 0.74 NPC1 (0.50) NPC1RAB9AALDH1A1GAASMN1; SMN2
SCHEMBL15722747 0.74 NPC1 (0.50) NPC1RAB9AALDH1A1GAASMN1; SMN2
SCHEMBL15722637 0.74 NPC1 (0.50) NPC1RAB9AALDH1A1GAASMN1; SMN2
SCHEMBL23185863 0.74 NPC1 (0.50) NPC1RAB9AALDH1A1GAASMN1; SMN2
SCHEMBL16851750 0.73 NPC1 (0.48) NPC1RAB9AALDH1A1GAALOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11091452-B2 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound ZEON CORPORATION (JP) 2021-08-17 US disclosed
US-10968189-B2 Method for producing 2-hydrazinobenzothiazole derivative DIC CORPORATION (JP) 2021-04-06 US disclosed
US-20200048213-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORPORATION (JP) 2020-02-13 US disclosed
US-10173992-B2 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound ZEON CORPORATION (JP) 2019-01-08 US disclosed
EP-2871192-B1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORP (JP) 2018-06-20 EP disclosed
US-9643942-B2 Method for manufacturing 1,1-disubstituted hydrazine compound ZEON CORPORATION (JP) 2017-05-09 US disclosed
US-9643942-B2 Method for manufacturing 1,1-disubstituted hydrazine compound ZEON CORPORATION (JP) 2017-05-09 US disclosed
US-9586917-B2 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound ZEON CORPORATION (JP) 2017-03-07 US disclosed
US-9586917-B2 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound ZEON CORPORATION (JP) 2017-03-07 US disclosed
US-20170008862-A1 METHOD FOR MANUFACTURING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND ZEON CORPORATION (JP) 2017-01-12 US disclosed
EP-3112356-A1 METHOD FOR MANUFACTURING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND Zeon Corporation (JP) 2017-01-04 EP disclosed
US-20160280672-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORPORATION (JP) 2016-09-29 US disclosed
US-20160280672-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORPORATION (JP) 2016-09-29 US disclosed
US-20150175564-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORPORATION (JP) 2015-06-25 US disclosed
US-20150175564-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORPORATION (JP) 2015-06-25 US disclosed
EP-2871192-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND Zeon Corporation (JP) 2015-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10173992-B2 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound PYM1, C5, C1S NPC1 3672/4885RAB9A 3942/4885ALDH1A1 987/4885
US-20200048213-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND PDE8A, MAPT, PLK4 NPC1 3200/4885RAB9A 3436/4885ALDH1A1 3468/4885
US-11091452-B2 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound PDE8A, MAPT, PLK4 NPC1 3200/4885RAB9A 3436/4885ALDH1A1 3468/4885
US-20170008862-A1 METHOD FOR MANUFACTURING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND HRH1, HBZ, H1-0 NPC1 2157/4885RAB9A 603/4885ALDH1A1 209/4885
US-20160280672-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND PYM1, C5, C1S NPC1 3672/4885RAB9A 3942/4885ALDH1A1 987/4885
US-20150175564-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND PYM1, C5, C1S NPC1 3672/4885RAB9A 3942/4885ALDH1A1 987/4885
US-10968189-B2 Method for producing 2-hydrazinobenzothiazole derivative HAO2, IDH2, HACL2 NPC1 2261/4885RAB9A 3845/4885ALDH1A1 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.